Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
3
Accepted by SEC
03 Apr 2026, 18:59:07 UTC
Prior SEC filing
23 Feb 2023
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
Monarch Alternative Capital LP; By: /s/ Christopher Santana, Chief Executive Officer

Key filing fact

Monarch Alternative Capital LP filed Form 3 for Capstone Green Energy Holdings, Inc. (CGEH) on 03 Apr 2026.

Key facts

  • This page summarizes Monarch Alternative Capital LP's Form 3 filing for Capstone Green Energy Holdings, Inc. (CGEH).
  • 0 reported transactions and 3 derivative rows are listed below.
  • Accepted by SEC: 03 Apr 2026, 18:59.

Change

  • Previous filing in this sequence was filed on 23 Feb 2023.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Official SEC source

Ownership activity is grounded in SEC Form 3 disclosures.

View source filing

Reporting Owners (3)

CIK 0001281084 Primary reporting owner

Monarch Alternative Capital LP

Relationship
10%+ Owner
Address
535 MADISON AVENUE, NEW YORK
Signature
Monarch Alternative Capital LP; By: /s/ Christopher Santana, Chief Executive Officer
Signature date
03 Apr 2026
CIK 0001501101

MDRA GP LP

Relationship
10%+ Owner
Address
C/O MONARCH ALTERNATIVE CAPITAL LP, 535 MADISON AVENUE, NEW YORK
Signature
MDRA GP LP; By: Monarch GP LLC, as general partner; By: /s/ Christopher Santana, Partnership Committee Member
Signature date
03 Apr 2026
CIK 0001501100

Monarch GP LLC

Relationship
10%+ Owner
Address
C/O MONARCH ALTERNATIVE CAPITAL LP, 535 MADISON AVENUE, NEW YORK
Signature
Monarch GP LLC; By: /s/ Christopher Santana, Partnership Committee Member
Signature date
03 Apr 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

CGEH holding

Voting Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
3,333,334
Date
31 Mar 2026
Ownership
See footnotes
Footnotes
F1
CGEH holding

Voting Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
3,333,334
Date
31 Mar 2026
Ownership
See footnotes
Footnotes
F1
CGEH holding

Voting Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
3,333,334
Date
31 Mar 2026
Ownership
See footnotes
Footnotes
F1

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

CGEH holding Derivative

Series A Convertible Preferred Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date
31 Mar 2026
Ownership
See footnotes
Underlying class
Voting Common Stock
Underlying amount
16,000,000
Exercise price
Footnotes
F1, F2
CGEH holding Derivative

Series A Convertible Preferred Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date
31 Mar 2026
Ownership
See footnotes
Underlying class
Voting Common Stock
Underlying amount
16,000,000
Exercise price
Footnotes
F1, F2
CGEH holding Derivative

Series A Convertible Preferred Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date
31 Mar 2026
Ownership
See footnotes
Underlying class
Voting Common Stock
Underlying amount
16,000,000
Exercise price
Footnotes
F1, F2
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

This Form 3 is being filed on behalf of Monarch Alternative Capital LP, a Delaware limited partnership ("MAC"), MDRA GP LP, a Delaware limited partnership ("MDRA GP"), and Monarch GP LLC, a Delaware limited liability company ("Monarch GP" and, together with MAC and MDRA GP, the "Reporting Persons"). MAC serves as the investment advisor to a variety of funds (such funds collectively, the "Monarch Funds"), with respect to the shares of the Issuer beneficially owned by it by virtue of the authority granted to it by the Monarch Funds to vote and dispose of the securities held by such Monarch Funds. MDRA GP is the general partner of MAC and Monarch GP is the general partner of MDRA GP. Each of MAC, MDRA GP and Monarch GP may be deemed to indirectly beneficially own shares held directly by the Monarch Funds and disclaims economic ownership of all such shares except to the extent of any indirect pecuniary interest therein.

Footnote F2

Consists of 80,000 shares of Series A Convertible Preferred Stock of the Issuer. The Series A Convertible Preferred Stock is convertible into shares of the Issuer's common stock at the option of the holder at an initial conversion price of $5.00 per share, subject to adjustment pursuant to the terms of the Certificate of Designation, and has no expiration date.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .